Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 6,871 | 6,881 | 0 | 2,540 | 2,506 |
| Operating Income | -6,871 | -6,881 | N/A | -2,540 | -2,506 |
| Other Income | 62 | -8 | 0 | 137 | 115 |
| Pre-tax Income | -6,809 | -6,889 | 0 | -2,403 | -2,391 |
| Income Tax | 3 | 6 | N/A | N/A | N/A |
| Net Income Continuous | -6,812 | -6,895 | N/A | -2,403 | -2,391 |
| Net Income | $-6,812 | $-6,895 | $N/A | $-2,403 | $-2,391 |
| EPS Basic Total Ops | -0.26 | -0.33 | N/A | -0.10 | -0.12 |
| EPS Basic Continuous Ops | -0.26 | -0.33 | N/A | -0.10 | -0.12 |
| EPS Diluted Total Ops | -0.26 | -0.33 | N/A | -0.10 | -0.12 |
| EPS Diluted Continuous Ops | -0.26 | -0.33 | N/A | -0.10 | -0.12 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.33 | N/A | N/A | N/A |
| EBITDA(a) | $-6,871 | $N/A | $N/A | $-2,540 | $-2,506 |